Yoko Imamichi

1.8k total citations
22 papers, 1.2k citations indexed

About

Yoko Imamichi is a scholar working on Neurology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yoko Imamichi has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 6 papers in Epidemiology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yoko Imamichi's work include Parkinson's Disease Mechanisms and Treatments (17 papers), Autophagy in Disease and Therapy (6 papers) and Neurological diseases and metabolism (4 papers). Yoko Imamichi is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (17 papers), Autophagy in Disease and Therapy (6 papers) and Neurological diseases and metabolism (4 papers). Yoko Imamichi collaborates with scholars based in Japan, Canada and Australia. Yoko Imamichi's co-authors include Nobutaka Hattori, Shinji Saiki, Kei‐ichi Ishikawa, Manabu Funayama, Yukiko Sasazawa, Motoki Fujimaki, Sumihiro Kawajiri, Masaya Imoto, Shigeto Sato and Isei Tanida and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Neurology.

In The Last Decade

Yoko Imamichi

22 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoko Imamichi Japan 16 538 476 302 229 220 22 1.2k
Chunli Duan China 19 542 1.0× 420 0.9× 208 0.7× 361 1.6× 302 1.4× 35 1.2k
Wei-Dong Le China 15 302 0.6× 403 0.8× 252 0.8× 207 0.9× 135 0.6× 24 936
Alexandre Henriques Brazil 16 725 1.3× 520 1.1× 184 0.6× 269 1.2× 352 1.6× 57 1.5k
Motoki Fujimaki Japan 14 275 0.5× 387 0.8× 289 1.0× 117 0.5× 201 0.9× 33 922
Yansu Guo China 21 593 1.1× 631 1.3× 175 0.6× 189 0.8× 246 1.1× 63 1.5k
Jason Schapansky Canada 11 377 0.7× 345 0.7× 169 0.6× 188 0.8× 361 1.6× 16 901
Bao Wang China 15 269 0.5× 384 0.8× 300 1.0× 150 0.7× 100 0.5× 42 977
Chulman Jo South Korea 22 187 0.3× 752 1.6× 363 1.2× 147 0.6× 390 1.8× 43 1.4k
Malle Kuum Estonia 13 256 0.5× 636 1.3× 314 1.0× 228 1.0× 279 1.3× 15 1.1k
C. Thong United States 18 419 0.8× 615 1.3× 152 0.5× 374 1.6× 344 1.6× 27 1.4k

Countries citing papers authored by Yoko Imamichi

Since Specialization
Citations

This map shows the geographic impact of Yoko Imamichi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Imamichi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Imamichi more than expected).

Fields of papers citing papers by Yoko Imamichi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Imamichi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Imamichi. The network helps show where Yoko Imamichi may publish in the future.

Co-authorship network of co-authors of Yoko Imamichi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Imamichi. A scholar is included among the top collaborators of Yoko Imamichi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Imamichi. Yoko Imamichi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saiki, Shinji, Hirotaka Matsumoto, Shin‐Ichi Ueno, et al.. (2022). Systemic Metabolic Alteration Dependent on the Thyroid‐Liver Axis in Early PD. Annals of Neurology. 93(2). 303–316. 7 indexed citations
2.
Ueno, Shin‐Ichi, Haruka Takeshige‐Amano, Shuji Suzuki, et al.. (2021). Non-invasive diagnostic tool for Parkinson’s disease by sebum RNA profile with machine learning. Scientific Reports. 11(1). 18550–18550. 17 indexed citations
3.
Takeshige‐Amano, Haruka, Shinji Saiki, Motoki Fujimaki, et al.. (2020). Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. Movement Disorders. 35(8). 1438–1447. 16 indexed citations
4.
Fujimaki, Motoki, Yukiko Sasazawa, Akihiro Yamaguchi, et al.. (2019). Neuroprotective effects of memantine via enhancement of autophagy. Biochemical and Biophysical Research Communications. 518(1). 161–170. 39 indexed citations
5.
Mori, Akio, Kei‐ichi Ishikawa, Shinji Saiki, et al.. (2019). Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy. PLoS ONE. 14(9). e0223113–e0223113. 10 indexed citations
6.
Fujimaki, Motoki, Norihiko Furuya, Shinji Saiki, et al.. (2019). Iron Supply via NCOA4-Mediated Ferritin Degradation Maintains Mitochondrial Functions. Molecular and Cellular Biology. 39(14). 60 indexed citations
7.
Ishikawa, Kei‐ichi, Shinji Saiki, Norihiko Furuya, et al.. (2018). p150glued deficiency impairs effective fusion between autophagosomes and lysosomes due to their redistribution to the cell periphery. Neuroscience Letters. 690. 181–187. 16 indexed citations
8.
Saiki, Shinji, Taku Hatano, Motoki Fujimaki, et al.. (2017). Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease. Scientific Reports. 7(1). 7328–7328. 107 indexed citations
9.
Yoshino, Hiroyo, Makito Hirano, A. Jon Stoessl, et al.. (2017). Homozygous alpha-synuclein p.A53V in familial Parkinson's disease. Neurobiology of Aging. 57. 248.e7–248.e12. 88 indexed citations
10.
Fujimaki, Motoki, Shinji Saiki, Yukiko Sasazawa, et al.. (2017). Immunocytochemical Monitoring of PINK1/Parkin-Mediated Mitophagy in Cultured Cells. Methods in molecular biology. 1759. 19–27. 9 indexed citations
11.
Nishioka, Kenya, Makito Hirano, A. Jon Stoessl, et al.. (2017). Homozygous alpha-synuclein a53v in familial parkinson's disease. Journal of the Neurological Sciences. 381. 161–161. 2 indexed citations
12.
Yamada, Daisuke, Shinji Saiki, Norihiko Furuya, et al.. (2016). Ethambutol neutralizes lysosomes and causes lysosomal zinc accumulation. Biochemical and Biophysical Research Communications. 471(1). 109–116. 15 indexed citations
13.
Ishikawa, Kei‐ichi, Shinji Saiki, Norihiko Furuya, et al.. (2014). p150glued-Associated Disorders Are Caused by Activation of Intrinsic Apoptotic Pathway. PLoS ONE. 9(4). e94645–e94645. 14 indexed citations
14.
Saiki, Shinji, Yukiko Sasazawa, Yoko Imamichi, et al.. (2011). Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy. 7(2). 176–187. 364 indexed citations
15.
Funayama, Manabu, Yuanzhe Li, Ching‐Wan Lam, et al.. (2008). Familial Parkinsonism with digenic parkin and PINK1 mutations. Movement Disorders. 23(10). 1461–1465. 39 indexed citations
16.
Tomiyama, Hiroyuki, Yuanzhe Li, Yoko Imamichi, et al.. (2008). Mutation Analysis of the PINK1 Gene in 391 Patients With Parkinson Disease. Archives of Neurology. 65(6). 802–8. 68 indexed citations
17.
Tomiyama, Hiroyuki, Yasumasa Kokubo, Ryogen Sasaki, et al.. (2008). Mutation analyses in amyotrophic lateral sclerosis/parkinsonism–dementia complex of the Kii peninsula, Japan. Movement Disorders. 23(16). 2344–2348. 24 indexed citations
18.
Mellick, George D., G. Siebert, Manabu Funayama, et al.. (2008). Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia. Parkinsonism & Related Disorders. 15(2). 105–109. 48 indexed citations
19.
Funayama, Manabu, Yuanzhe Li, Hiroyuki Tomiyama, et al.. (2007). Leucine-Rich Repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population. Neuroreport. 18(3). 273–275. 98 indexed citations
20.
Kobayashi, Tomonori, et al.. (2003). Pseudo-autosomal dominant inheritance of PARK2: two families with parkin gene mutations. Journal of the Neurological Sciences. 207(1-2). 11–17. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunli Duan Breakdown of academic impact, for papers by Wei-Dong Le Breakdown of academic impact, for papers by Alexandre Henriques Breakdown of academic impact, for papers by Motoki Fujimaki Breakdown of academic impact, for papers by Yansu Guo Breakdown of academic impact, for papers by Jason Schapansky Breakdown of academic impact, for papers by Bao Wang Breakdown of academic impact, for papers by Chulman Jo Breakdown of academic impact, for papers by Malle Kuum Breakdown of academic impact, for papers by C. Thong
Rankless by CCL
2026